Synthetic farnesoid X receptor agonists induce high-density lipoprotein-mediated transhepatic cholesterol efflux in mice and monkeys and prevent atherosclerosis in cholesteryl ester transfer protein transgenic low-density lipoprotein receptor (-/-) mice. 2012

Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
Phenex Pharmaceuticals AG, Heidelberg, Germany.

Farnesoid X receptor (FXR), a bile acid-activated nuclear hormone receptor, plays an important role in the regulation of cholesterol and more specifically high-density lipoprotein (HDL) homeostasis. Activation of FXR is reported to lead to both pro- and anti-atherosclerotic effects. In the present study we analyzed the impact of different FXR agonists on cholesterol homeostasis, plasma lipoprotein profiles, and transhepatic cholesterol efflux in C57BL/6J mice and cynomolgus monkeys and atherosclerosis development in cholesteryl ester transfer protein transgenic (CETPtg) low-density lipoprotein receptor (LDLR) (-/-) mice. In C57BL/6J mice on a high-fat diet the synthetic FXR agonists isopropyl 3-(3,4-difluorobenzoyl)-1,1-dimethyl-1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate (FXR-450) and 4-[2-[2-chloro-4-[[5-cyclopropyl-3-(2,6-dichlorophenyl)-4-isoxazolyl]methoxy]phenyl]cyclopropyl]benzoic acid (PX20606) demonstrated potent plasma cholesterol-lowering activity that affected all lipoprotein species, whereas 3-[2-[2-chloro-4-[[3-(2,6-dichlorophenyl)-5-(1-methylethyl)-4-isoxazolyl]methoxy]phenyl]ethenyl]benzoic acid (GW4064) and 6-ethyl chenodeoxycholic acid (6-ECDCA) showed only limited effects. In FXR wild-type mice, but not FXR(-/-) mice, the more efficacious FXR agonists increased fecal cholesterol excretion and reduced intestinal cholesterol (re)uptake. In CETPtg-LDLR(-/-) mice PX20606 potently lowered total cholesterol and, despite the observed HDL cholesterol (HDLc) reduction, caused a highly significant decrease in atherosclerotic plaque size. In normolipidemic cynomolgus monkeys PX20606 and 6-ECDCA both reduced total cholesterol, and PX20606 specifically lowered HDL(2c) but not HDL(3c) or apolipoprotein A1. That pharmacological FXR activation specifically affects this cholesterol-rich HDL(2) subclass is a new and highly interesting finding and sheds new light on FXR-dependent HDLc lowering, which has been perceived as a major limitation for the clinical development of FXR agonists.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D011973 Receptors, LDL Receptors on the plasma membrane of nonhepatic cells that specifically bind LDL. The receptors are localized in specialized regions called coated pits. Hypercholesteremia is caused by an allelic genetic defect of three types: 1, receptors do not bind to LDL; 2, there is reduced binding of LDL; and 3, there is normal binding but no internalization of LDL. In consequence, entry of cholesterol esters into the cell is impaired and the intracellular feedback by cholesterol on 3-hydroxy-3-methylglutaryl CoA reductase is lacking. LDL Receptors,Lipoprotein LDL Receptors,Receptors, Low Density Lipoprotein,LDL Receptor,LDL Receptors, Lipoprotein,Low Density Lipoprotein Receptor,Low Density Lipoprotein Receptors,Receptors, Lipoprotein, LDL,Receptor, LDL,Receptors, Lipoprotein LDL
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal

Related Publications

Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
June 1991, The Journal of biological chemistry,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
August 2013, Journal of lipid research,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
November 2022, Cardiovascular research,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
December 1999, The Journal of biological chemistry,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
November 2006, Arteriosclerosis, thrombosis, and vascular biology,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
June 1996, European journal of clinical investigation,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
August 1984, The Journal of biological chemistry,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
December 1990, European journal of clinical investigation,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
August 2001, Current opinion in lipidology,
Eva Hambruch, and Shinobu Miyazaki-Anzai, and Ulrike Hahn, and Silke Matysik, and Alfred Boettcher, and Sanja Perović-Ottstadt, and Thomas Schlüter, and Olaf Kinzel, and Helen Desiree Krol, and Ulrich Deuschle, and Michael Burnet, and Moshe Levi, and Gerd Schmitz, and Makoto Miyazaki, and Claus Kremoser
October 1997, Journal of lipid research,
Copied contents to your clipboard!